Companies: 10,795·Total market cap: $144.5T
Amarin Corporation plc

Amarin Corporation plc

AMRNNASDAQHealthcare● Active
$14.15
+$0.22(+1.58%)
Market Cap$292661252
P/E Ratio
52W High$20.9
52W Low$11.65
Overview

Amarin Corporation plc (AMRN) Stock Forecast & Analyst Price Target

Wall Street consensus, 12-month price targets, model projections, and EPS/revenue estimates — from analyst data and price history.

amrn · stock forecast · 18 analysts (3M) · FMP · updated Jun 8, 2026

Analyst Rating & Consensus

Based on 18 Wall Street analysts in the past 3 months

SellBuy

Hold

18 analysts

consensus

Rating Breakdown

Strong Buy
0
Buy
3
Hold
13
Sell
2
Strong Sell
0
Total: 18 · Buy rate: 16.7%

12-Month Price Target

High

$3.00

Consensus

$2.17

-84.4% upside

Low

$1.50

Median: $2 · Last Close: $13.93

The Amarin Corporation plc (AMRN) analyst consensus is Hold, based on ratings from 18 Wall Street analysts over the past 3 months. The average 12-month AMRN price target is $2.17, representing -84.4% upside from the current price of $13.93.

12-Month Price Target Forecast

Historical closing prices + analyst 12-month price target forecast cone

Historical priceConsensus $2 (-84.4%)

Consensus Target

$2.17

-84.4% upside

High Target

$3

-78.5%

Low Target

$1.5

-89.2%

Current Price

$13.93

as of today

Based on analyst price targets, the AMRN stock price prediction for the next 12 months ranges from $1.5 to $3. The consensus AMRN price forecast of $2.17 implies -84.4% upside from the current price of $13.93.

Short-Term Price Prediction

Algorithmically generated · Updated daily

DatePredicted PriceChange
2026-06-09$13.771.12%

1-day model range: $13.73–$13.82. Peak: $13.82 (-1.12%).

Long-Term Stock Price Prediction

Annual stock price forecast · 2027 / 2028 / 2029 / 2030 / 2031

YearAvg PriceChange
2027$10-30.9%
2028$8-41.5%
2029$8-46.1%
2030$7-48.1%
2031-49.1%
Confidence:Medium

Stock Forecast Based on Technical Analysis

14 TA signals (SMA×6 + EMA×6 + RSI + MACD) · EEAT method transparency

Market Sentiment

BEARISH

Based on 14 technical indicators

0%7%93%
0Buy
1Neutral
13Sell
RSI (14)38.9Neutral
MACDBEARISH

Refreshes daily from EOD close

Moving Averages · AMRN · Jun 8, 2026

Simple Moving Average (SMA)
MA 5$14.22SELL
MA 10$14.32SELL
MA 20$14.48SELL
MA 50$14.50SELL
MA 100$14.78SELL
MA 200$15.40SELL
Current $AMRN · Price above MA = BUY signal
Exponential Moving Average (EMA)
EMA 5$14.14SELL
EMA 10$14.26SELL
EMA 20$14.37SELL
EMA 50$14.52SELL
EMA 100$14.72SELL
EMA 200$14.73SELL
Current $AMRN · Price above MA = BUY signal
How we calculate: Technical sentiment is derived from 14 indicators — SMA(5,10,20,50,100,200), EMA(5,10,20,50,100,200), RSI(14), and MACD(12,26,9) — calculated from historical EOD price data. BUY = current price above MA; SELL = below. 14 TA signals + historical EOD price data · Updated daily. Independent of analyst consensus data. Not investment advice.

Latest Analyst Ratings & Upgrades

Filter:
Goldman Sachs2025-06-25
Maintains
SellSell
Goldman Sachs2025-04-17
Maintains
SellSell
Jefferies2023-10-25
Downgrade ↓
BuyHold
Goldman Sachs2023-07-20
Maintains
SellSell
Northland Capital Markets2023-07-19
Maintains
Market PerformMarket Perform
Jefferies2023-01-06
Upgrade ↑
HoldBuy
SVB Leerink2022-10-19
Maintains
Market PerformMarket Perform
Goldman Sachs2022-05-24
Maintains
SellSell
JP Morgan2022-05-06
Downgrade ↓
NeutralUnderweight
SVB Leerink2022-05-05
Downgrade ↓
OutperformMarket Perform

Wall Street analysts have recently issued updated ratings on Amarin Corporation plc (AMRN) stock. Of the recent 62 rating actions, 8 were upgrades and 22 were downgrades. 18 analysts currently cover AMRN.

Analyst Recommendation Trends

Buy ratings00
Hold ratings101
Sell ratings01↑ +1

AMRN analyst recommendation trends show stable buy-side sentiment over the past 6 months. Buy rating actions changed from 0 to 0 per month.

Financial Forecast: EPS & Revenue Estimates

Revenue This Year

$222M

↑ 15.3% YoY

Revenue Next Year

$182M

↓ 18.1% YoY

EPS This Year

$-0.66

EPS Next Year

$-0.04

↓ 94.7% YoY

EPS ForecastReported vs Estimated

Reported EPSHistorical estimateAnalyst forecast (future)

Analysts forecast AMRN EPS of $-0.66 for the current fiscal year, based on estimates from 1 analysts. The AMRN revenue forecast is $222M for the current year. These are analyst consensus estimates via FMP / S&P Global.

About Forecast & Price Prediction

The AMRN stock forecast is supported by two independent data sources: analyst consensus ratings from 18 Wall Street analysts (S&P Global / FMP), and technical analysis calculated from historical EOD price data. The consensus AMRN price target is $2.17 (-84.4% upside), with an analyst consensus of Hold.

The AMRN short-term stock prediction for tomorrow is $13.77 (-1.12%). The AMRN stock price prediction for 2027 estimates an average of $10. The AMRN stock prediction for 2030 projects a range of $7–$7.

Amarin Corporation plc trades on NASDAQ under the ticker AMRN. The AMRN stock outlook for 2027 is broadly mixed, supported by a Hold consensus among 17% of covering analysts.

FAQ answers synthesize analyst targets, estimates, and on-page model outputs where shown.

Frequently asked questions

AMRN forecast · 8 questions

According to 18 Wall Street analysts, the average 12-month AMRN price target is $2.17, with a high forecast of $3.00 and a low of $1.50. The median price target is shown in the chart above when available. This implies -84.4% potential upside from the current price of $13.93.

AMRN price targetWhat is AMRN price targetAMRN analyst price targetAMRN 12-month target

· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)

⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.